Insider · CIK 0001407235

Garner William J

Reports to the SEC for 3 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001407235

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-01-24	INMInMed Pharmaceuticals Inc. · Employee Stock Option (Expiration)H Expiration (Short)	Director	HExpiration (Short)	−24.2K sh	—	—	16,122
2021-12-29	INMInMed Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	40,364
2020-12-16	INMInMed Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2015-07-16	HURATuHURA Biosciences, Inc./NV · WarrantP Purchase	Director	PPurchase	+16.7K sh	$0.00	+$16.666	16,666
2015-07-16	HURATuHURA Biosciences, Inc./NVP Purchase	Director	PPurchase	+16.7K sh	$0.60	+$9,999.6	2,415,207
2014-03-18	HURATuHURA Biosciences, Inc./NV · Exchangeable SharesC Conversion	Director	CConversion	−80K sh	—	—	2,438,541
2014-03-18	HURATuHURA Biosciences, Inc./NVS Sale	Director	SSale	−25K sh	$1.30	−$32.5K	65,000
2014-03-18	HURATuHURA Biosciences, Inc./NVS Sale	Director	SSale	−25K sh	$1.30	−$32.5K	40,000
2014-03-18	HURATuHURA Biosciences, Inc./NVS Sale	Director	SSale	−10K sh	$1.30	−$13K	30,000
2014-03-18	HURATuHURA Biosciences, Inc./NVS Sale	Director	SSale	−10K sh	$1.30	−$13K	20,000
2014-03-18	HURATuHURA Biosciences, Inc./NVS Sale	Director	SSale	−10K sh	$1.30	−$13K	10,000
2014-03-18	HURATuHURA Biosciences, Inc./NV · Exchangeable SharesC Conversion	Director	CConversion	−80K sh	$0.01	−$400	2,513,541
2014-03-18	HURATuHURA Biosciences, Inc./NVC Conversion	Director	CConversion	+80K sh	—	—	90,000
2013-11-26	HURATuHURA Biosciences, Inc./NVC Conversion	Director	CConversion	+5,000 sh	—	—	10,000
2013-11-26	HURATuHURA Biosciences, Inc./NV · Warrants (Right to Buy)C Conversion	Director	CConversion	−5,000 sh	—	—	45,000
2013-09-20	HURATuHURA Biosciences, Inc./NVP Purchase	Director	PPurchase	+5,000 sh	$1.00	+$5,000	5,000
2013-08-16	HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award	Director	AAward	+120K sh	—	—	120,000
2009-03-13	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+1,000 sh	$0.09	+$90	18,586,340
2009-03-13	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+1,000 sh	$0.09	+$90	18,587,340
2009-03-11	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+1,000 sh	$0.09	+$90	18,585,340
2009-03-05	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+5,000 sh	$0.08	+$400	18,584,340
2009-02-25	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+1,000 sh	$0.10	+$100	18,579,340
2009-01-30	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+7,800 sh	$0.14	+$1,092	18,568,340
2009-01-30	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+10K sh	$0.13	+$1,300	18,578,340
2009-01-29	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+16K sh	$0.15	+$2,400	18,560,540
2009-01-27	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+5,000 sh	$0.10	+$500	18,539,540
2009-01-27	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+5,000 sh	$0.14	+$700	18,544,540
2009-01-26	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+5,000 sh	$0.17	+$850	18,534,540
2009-01-21	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+43K sh	$0.10	+$4,300	18,529,540
2009-01-21	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+48K sh	$0.04	+$2,160	18,529,540
2009-01-21	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+5,000 sh	$0.09	+$450	18,486,540
2009-01-20	Vaneltix Pharma, Inc.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+5,000 sh	$0.04	+$225	18,481,540

Recent filings

Accepted (ET)
Jan 244
Garner William J0001213900-22-003334
SEC(opens sec.gov)
Dec 304
Garner William J0001213900-21-068183
SEC(opens sec.gov)
Dec 184
Garner William J0001213900-20-043362
SEC(opens sec.gov)
Jul 174
DelMar Pharmaceuticals, Inc.0001013762-15-000734
SEC(opens sec.gov)
Oct 314/A
DelMar Pharmaceuticals, Inc.0001013762-14-001273
SEC(opens sec.gov)
Mar 204
DelMar Pharmaceuticals, Inc.0001013762-14-000263
SEC(opens sec.gov)
Nov 274
DelMar Pharmaceuticals, Inc.0001013762-13-001487
SEC(opens sec.gov)
Sep 234
DelMar Pharmaceuticals, Inc.0001013762-13-001248
SEC(opens sec.gov)
Aug 224
DelMar Pharmaceuticals, Inc.0001013762-13-001176
SEC(opens sec.gov)
Mar 184
Garner William J0001013762-09-000456
SEC(opens sec.gov)
Mar 164
Garner William J0001013762-09-000433
SEC(opens sec.gov)
Mar 134
Garner William J0001013762-09-000421
SEC(opens sec.gov)

Companies

Address

C/O URIGEN PHARMACEUTICALS, INC. 27 MAIDEN LANE

SAN FRANCISCO, CA, 94108